Quantcast

Latest Channelopathy Stories

2009-04-02 16:01:00

OMAHA, Neb., April 2 /PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO). In a peer-reviewed paper published in the February 2009 issue of the journal Human Mutation, a team at Weill Cornell Medical College New York describes in detail the key advantages of using Transgenomic's Surveyor Nuclease technology for mutation scanning of PKD1 and PKD2, two important genes used in the diagnosis and prognosis of autosomal dominant polycystic kidney disease (ADPKD). The assay...

2009-03-24 09:17:58

A U.S.-German study has linked 10 genes with sudden cardiac death, a condition that accounts for 450,000 U.S. deaths annually. Irregular heart rhythms commonly result in sudden cardiac death and now scientists are closer to understanding what causes the condition and who it might strike, said University of Michigan Associate Professor Goncalo Abecasis, a co-leader of the research. The team identified 10 genes associated with changes in the so-called QT interval duration. The QT interval...

2009-03-05 11:20:23

U.S. medical scientists involved in an international study say they've identified a gene that modifies lung disease severity in people with cystic fibrosis. Wake Forest University Baptist Medical Center researchers said the research is the first published study to search the entire genome looking for genes that modify the severity of cystic fibrosis lung disease. Carl Langefeld, a study co-author and Wake Forest University School of Medicine researcher, said the findings might help in the...

2008-11-11 09:00:08

Clinical Data, a biotechnology company, has announced that its PGxHealth division has launched a new genetic test for arrhythmogenic right ventricular cardiomyopathy, an inherited and often fatal heart condition. The Familion arrhythmogenic right ventricular cardiomyopathy (ARVC) test is a complex genetic test that sequences the five genes most commonly associated with ARVC (PKP2, DSP, DSG2, DSC2 and TMEM43) and is performed in a CLIA-certified commercial laboratory that meets all...

2008-10-29 15:00:27

LOS ANGELES, Oct. 29 /PRNewswire/ -- Inspired by his own life-saving kidney transplant, fashion critic and Entertainment Tonight correspondent Steven "Cojo" Cojocaru is taking steps to help the 12.5 million people worldwide affected by Polycystic Kidney Disease (PKD). PKD is one of the world's most common, life-threatening genetic diseases, affecting more people than Down syndrome, cystic fibrosis, muscular dystrophy and sickle cell anemia ... combined. PKD affects 1 in 500 children and...

2008-10-27 15:00:09

U.S. scientists say they've developed a simple gene-based blood test that can more accurately and quickly measure cystic fibrosis patients' therapy response. Researchers at National Jewish Medical and Research Center said the test, a measure of inflammatory gene expression, could improve patient care and help clear a backlog of promising medications now hung up in clinical trials. "The currently accepted test, a measure of a patients' ability to exhale air, has several limitations that...

2008-10-21 09:00:54

CUMBERLAND, R.I., Oct. 21 /PRNewswire/ -- Neurotech Pharmaceuticals, Inc., a privately-held biotechnology company focused on the development of sight-saving therapeutics for chronic retinal diseases, announced today the opening of its new 27,000 square-foot GMP manufacturing facility in Cumberland, Rhode Island. With support from the Rhode Island Economic Development Corporation (RIEDC) and its financing programs, Rhode Island Industrial Facilities Corporation (RIIFC) and Rhode Island...

2008-10-21 06:00:24

EPIX Pharmaceuticals, Inc. (NASDAQ: EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform, today announced that Martin Mense, Ph.D., principal scientist and head of Cystic Fibrosis biology at EPIX, is scheduled to present at the 22nd Annual North American Cystic Fibrosis Conference on Friday, October 24, 2008. Dr. Mense will participate in a symposium entitled...

2008-10-13 09:00:09

Kamada, a biopharmaceutical company, has reported positive data from its Phase II study evaluating inhaled Alpha-1 Antitrypsin delivered via an investigational eFlow Nebulizer System, in the treatment of cystic fibrosis. The results demonstrate the product has an excellent safety profile and shows promising signs of efficacy, as indicated by a reduction in lung inflammation, the company said. The Phase II trial was a double-blind, placebo-controlled study, performed at the Cystic Fibrosis...

2008-10-01 09:00:09

REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) (www.regenerx.com) announced today that it is seeking a strategic partner to assist in the development of RGN-457 for the treatment of cystic fibrosis (CF). RGN-457 is based on thymosin beta 4 (TB4) peptide formulated as an inhaled therapeutic agent to address this patient population. CF is a life-threatening, hereditary disease that impairs the patient's ability to breathe due to the accumulation of thick and sticky mucus secretions in the airways...


Latest Channelopathy Reference Libraries

Cystic Fibrosis
2013-07-19 15:03:45

Cystic fibrosis, also called mucoviscidosis, is an autosomal recessive genetic disorder of the viscous secretions in the body. In turn, it effects the lungs, pancreas, liver, and intestines, as well as all other exocrine glands in the body. The most common genetic mutation that causes CF is a deletion of three nucleotides that results in a loss of phenylalanine, an amino acid at the 508th position on the protein. It should be noted, however, that there are over a thousand other mutations that...

More Articles (1 articles) »
Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related